HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sudhakar Bangera Selected Research

Therapeutics

2/2010Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sudhakar Bangera Research Topics

Disease

1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2019
1Newborn Respiratory Distress Syndrome
01/2019
1Hypoglycemia (Reactive Hypoglycemia)
10/2014
1Obesity
10/2014
1Diabetes Mellitus
10/2014
1Hypertension (High Blood Pressure)
10/2014
1Dyslipidemias (Dyslipidemia)
10/2014
1Skin Neoplasms (Skin Cancer)
01/2013
1Pulmonary Arterial Hypertension
02/2010
1Dyspnea (Shortness of Breath)
02/2010

Drug/Important Bio-Agent (IBA)

1beractant (Survanta)FDA Link
01/2019
1goat lung surfactant extractIBA
01/2019
1Surface-Active Agents (Surfactants)IBA
01/2019
1Dipeptidyl-Peptidase IV InhibitorsIBA
10/2014
1Blood Glucose (Blood Sugar)IBA
10/2014
1Sunscreening Agents (Sunscreens)IBA
01/2013
1Biomarkers (Surrogate Marker)IBA
02/2010
1treprostinilFDA Link
02/2010

Therapy/Procedure

1Glycemic Control
10/2014
1Therapeutics
02/2010